Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Intracept by Boston Scientific logo — company profile

Intracept by Boston Scientific

Founded 2006 United States Minneapolis, United States 206 employees Series G Total: $273.55M Biotechnology, Health Care

General Information

Company Name Intracept by Boston Scientific
Founded Year 2006
Location United States Minneapolis, United States +2
Founders / Decision Makers
Team member
Employees 206
Industries Biotechnology, Health Care
Funding Stage Series G
Social

Get notified when Intracept by Boston Scientific moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Intracept by Boston Scientific

Relievant Medsystems, Inc., founded in 2006 and headquartered in the United States, is a leading medical device company in the biotechnology and healthcare industries, with offices in Minneapolis, MN, and Sunnyvale, CA. The company focuses on developing innovative solutions to enhance the quality of life for millions of patients suffering from chronic vertebrogenic low back pain. Its flagship product, the Intracept® System, is a minimally invasive procedure that delivers targeted energy into the spine, effectively blocking the transmission of pain signals from the basivertebral nerve. This pioneering approach provides spine surgeons and interventional spine physicians with a clinically proven method for long-lasting pain relief. The company recently secured a substantial $50.00M Series G investment on 27th March 2023, attracting support from prominent investors including New Enterprise Associates, Canaan Partners, Lightstone Ventures, Morgenthaler Ventures, Ally Bridge Group, Endeavour Vision, and Vensana Capital. This sizable investment underscores strong investor confidence in Relievant Medsystems' innovative technology and its potential to revolutionize the treatment of chronic vertebrogenic low back pain, addressing a significant unmet medical need in the healthcare market. With its compelling value proposition and support from reputable investors, Relievant Medsystems is well-positioned for growth and continued impact in the healthcare industry.

Taxonomy: medical device, spine, chronic pain, minimally invasive, interventional spine, vertebrogenic low back pain, pain relief, spine surgeons, nervous system, innovation

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Series G •••••• 7
Investor Investor Investor Investor Investor Investor Investor
27 Mar 2023
Series F •••••• 6
Investor Investor Investor Investor Investor Investor
29 Oct 2020
Series E •••••• 5
Investor Investor Investor Investor
•••• •••• 		26 Jun 2018
Series D •••••• 4
Investor Investor Investor Investor
11 Oct 2016
Debt Financing •••••• - 22 Dec 2015

View All 9 Funding Rounds

Intracept by Boston Scientific Alternatives & Competitors

Intracept by Boston Scientific vs
SmartImplantSystems
SmartImplantSystems

Offering groundbreaking spine implants for chronic back pain, allowing patients to reclaim their dai...

Seed
Health Care, Manufacturing
Intracept by Boston Scientific vs
Spine Team Texas
Spine Team Texas United States

Be a part of a Top 100 Place to Work by The Dallas Morning News. Start your career with us TODAY!

166 employees
Health Care
Intracept by Boston Scientific vs
Centurion Spine & Pain Centers
Centurion Spine & Pain Centers United States

Board certified physicians providing progressive interventional pain management treatments & procedu...

23 employees
Health Care
Also compare with: Intracept by Boston Scientific vs Columbia Pain Management, P.C. Columbia Pain Management, P.C. Intracept by Boston Scientific vs PainTEQ PainTEQ

FAQ About Intracept by Boston Scientific

Founded in 2006 with offices in Minneapolis, MN and Sunnyvale, CA, Relievant Medsystems is a privately held medical device company developing new solutions to improve the quality of life for millions of patients suffering from chronic vertebrogenic low back pain. Relievant’s Intracept® System delive...
Intracept by Boston Scientific was founded in 2006.
Intracept by Boston Scientific is headquartered in Minneapolis, United States.
Intracept by Boston Scientific operates in the following industries: Biotechnology, Health Care.
Intracept by Boston Scientific has approximately 206 employees.
Intracept by Boston Scientific has completed 9 funding rounds, raising a total of $273.55M. The latest funding stage is Series G.
Top alternatives and competitors to Intracept by Boston Scientific include SmartImplantSystems, Spine Team Texas, Centurion Spine & Pain Centers, Columbia Pain Management, P.C., Jax Spine and Pain Centers . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Intracept by Boston Scientific and SmartImplantSystems are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Intracept by Boston Scientific and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes